New US website makes clinical trials easy to find

May 2, 2013 by Kerry Sheridan

A US doctor has created a website to make it easier for the world's sickest people to connect with research that could potentially save their lives.

The non-profit endeavor known as MyClinicalTrialLocator.com aims to become "the of clinical trials," by allowing a quick and free search for studies at academic centers around the globe, said its founder Bruce Moskowitz.

It also seeks to provide an easier experience than the -run website ClinicalTrials.gov, which critics say is difficult to navigate and understand—but nevertheless serves as the industry standard.

MyClinicalTrialLocator.com is "really a resource for everybody, worldwide, for free," said Moskowitz, a physician in , Florida, whose mobile patient population—many of whom migrate north for the summer—gave him the idea of finding better ways to .

The new site contains trials run by academic centers on a wide range of topics including cancer, anxiety and . And one month after its launch, its database already boasts 141,923 trials from around the world.

That's quite close to the National Institutes of Health's ClinicalTrials.gov, which includes more than 144,000 trials in all 50 US states and 185 countries.

Moskowitz, 64, hopes the new site will improve the quality of research by diversifying the pool of candidates in various studies, and will help identify where money and time is being lost.

"It is going to be a revelation to see how many clinical trials are duplicated from ones outside North America without anyone knowing it's already been done and wasting money," he told AFP.

The new site is an open-source platform, so academic centers can send in their own information. It updates automatically and can send users alerts when a trial status changes or a new trial opens up.

It also allows patients to email a doctor in any country to find out about a clinical trial, Moskowitz said.

Developing the site took about a year, and was assisted with the input of 150 professionals from leading academic and medical centers in the United States including the Mayo Clinic, Johns Hopkins, Columbia Presbyterian, Stanford University, Duke University, and Massachusetts General Hospital, he said.

Some consumers and medical professionals have complained about Clinicaltrials.gov, saying it takes too long to search and is hard to understand.

"You almost have to be a physician or an oncologist with the dot-gov site to be able to decipher what a lot of the factors are," said Cassie Kautzmann, a 54-year-old cancer survivor who said she frequently googles for medical information instead.

Kautzmann was diagnosed in 2007 with leiomyosarcoma, a rare cancer. She has already taken part in two clinical trials, which brought her back from the brink of death.

"Right now I am in remission but that is probably doing to be short-lived," she told AFP. She said she hopes the new website will help find her next experimental treatment.

However, some experts believe that ClinicalTrials.gov is not going away any time soon.

The government registry was started in 1997 and by 2007 it became mandatory for researchers to use it to record data on most middle and late-stage trials regarding intervention drugs and devices.

Many respected peer-reviewed medical journals also require that studies be registered with ClinicalTrials.gov before they can be considered for publication.

One group, known as the Clinical Trials Transformation Initiative, uses ClinicalTrials.gov to look for ways that research as a whole is falling short, such as by trending toward studies that are too small or lacking in scientific rigor.

Bradford Hirsch, assistant professor of medicine at Duke University and a researcher with CTTI, said he has heard of other attempts to improve on the government database.

"What we have found is that the basis has to still be ClinicalTrials.gov because of mandated registration by the FDA as well as by the medical journal editors," Hirsch told AFP.

"It would be unlikely that anybody could really take the place of ClinicalTrials.gov, so our biggest focus is on continuing to improve that and other large registration sites in the US and outside with the obvious hope that other mechanisms will come up that can really make it more robust."

When asked to respond to criticism of the government's site, a spokeswoman from the NIH said in an email: "We are always pleased when data from ClinicalTrials.gov are used by different sources in different ways to increase access to information about ."

Explore further: Many NIH-funded clinical trials go unpublished over two years after completion

Related Stories

Many NIH-funded clinical trials go unpublished over two years after completion

January 4, 2012
In a study that investigates the challenges of disseminating clinical research findings in peer-reviewed biomedical journals, Yale School of Medicine researchers have found that fewer than half of a sample of trials primarily ...

Cancer research often falls short: study

April 29, 2013
Cancer research tends to involve small studies focused on a single therapy, often falling short of scientific standards seen in other medical investigations, said a study released Monday.

Clinical trials published almost two years after completion

March 6, 2013
(HealthDay)—Clinical trials are published, on average, almost two years after completion, with time to publication affected by the funding source, number of trial participants, and journal impact factor, according to a ...

Clinical trials helped one woman's fight against cancer

April 18, 2013
(HealthDay)—Monica Barlow, a 35-year-old from Maryland, was training for a half-marathon when she noticed she couldn't shake a bad cough and ongoing fatigue. After a couple of rounds of antibiotics from an urgent care clinic ...

Clinical trials often fall short

May 1, 2012
Clinical studies registered in clinicaltrials.gov between 2007-2010 are dominated by small, single-center trials and contain significant heterogeneity (different in nature, difficult to compare) in methodological approaches, ...

Treatments, not prevention, dominate diabetes research

April 5, 2013
Research for diabetes is far more focused on drug therapies than preventive measures, and tends to exclude children and older people who have much to gain from better disease management, according to a Duke Medicine study.

Recommended for you

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...

Team eradicates hepatitis C in 10 patients following lifesaving transplants from infected donors

April 30, 2017
Ten patients at Penn Medicine have been cured of the Hepatitis C virus (HCV) following lifesaving kidney transplants from deceased donors who were infected with the disease. The findings point to new strategies for increasing ...

'bench to bedside to bench': Scientists call for closer basic-clinical collaborations

March 24, 2017
In the era of genome sequencing, it's time to update the old "bench-to-bedside" shorthand for how basic research discoveries inform clinical practice, researchers from The Jackson Laboratory (JAX), National Human Genome Research ...

The ethics of tracking athletes' biometric data

January 18, 2017
(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Financial ties between researchers and drug industry linked to positive trial results

January 18, 2017
Financial ties between researchers and companies that make the drugs they are studying are independently associated with positive trial results, suggesting bias in the evidence base, concludes a study published by The BMJ ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.